Black Hawk Acquisition (BKHAU) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $9.69, -11.91% vs the prior close of $11.00.
- Volume 151 shares, 0.0x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
BKHAU slides 11.9% to $9.69, a 52-week low, 3 down days in a row. Closed at $9.69, -11.91% vs the prior close of $11.00. Day range $9.69–$9.69, opened at $9.69.
BKHAU daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — BKHAU slides 11.9% to $9.69, a 52-week low, 3 down days in a row
- Closed at $9.69, -11.91% vs the prior close of $11.00. Day range $9.69–$9.69, opened at $9.69.
- Volume was 151 shares, 0.1x its 50-day average of 1.69K — lighter than usual.
- Price is -20.0% vs its 50-day average ($12.11) and -20.0% vs its 200-day average ($12.11).
- 52-week range $9.69–$16.27; today's close sits at 0% of that range, 40.4% below the 52-week high.
- That makes 3 straight losses.
Oct 14, 2026 — BKHAU slides 12.7% to $11.00, a 52-week low
- Closed at $11.00, -12.70% vs the prior close of $12.60. Day range $10.80–$11.90, opened at $11.00.
- Volume was 2.68K shares, 1.6x its 50-day average of 1.63K.
- Price is -9.5% vs its 50-day average ($12.16) and -9.3% vs its 200-day average ($12.12).
- 52-week range $10.70–$16.27; today's close sits at 5% of that range, 32.4% below the 52-week high.
Oct 13, 2026 — BKHAU slides 3.2% to $12.60 on 7.5x normal volume
- Closed at $12.60, -3.15% vs the prior close of $13.01. Day range $11.26–$14.80, opened at $13.80.
- Volume was 10.86K shares, 7.5x its 50-day average of 1.45K — unusually heavy trading.
- Price is +3.5% vs its 50-day average ($12.18) and +3.9% vs its 200-day average ($12.13).
- 52-week range $10.70–$16.27; today's close sits at 34% of that range, 22.6% below the 52-week high.
- SEC filings that day: 8-K.
Oct 12, 2026 — BKHAU rises 2.7% to $13.01, a 3-month high on 29.7x normal volume
- Closed at $13.01, +2.68% vs the prior close of $12.67. Day range $12.64–$15.90, opened at $12.64.
- Volume was 27.15K shares, 29.7x its 50-day average of 915 — unusually heavy trading.
- Price is +6.9% vs its 50-day average ($12.17) and +7.3% vs its 200-day average ($12.13).
- 52-week range $10.70–$16.27; today's close sits at 41% of that range, 20.0% below the 52-week high.
- That makes 3 straight gains.
Oct 9, 2026 — BKHAU rises 0.3% to $12.67 on 11.3x normal volume
- Closed at $12.67, +0.32% vs the prior close of $12.63. Day range $12.32–$14.80, opened at $13.50.
- Volume was 8.64K shares, 11.3x its 50-day average of 762 — unusually heavy trading.
- Price is +4.3% vs its 50-day average ($12.15) and +4.5% vs its 200-day average ($12.12).
- 52-week range $10.70–$16.27; today's close sits at 35% of that range, 22.1% below the 52-week high.
Oct 8, 2026 — BKHAU jumps 3.1% to $12.63 on 51.1x normal volume
- Closed at $12.63, +3.10% vs the prior close of $12.25. Day range $12.10–$16.27, opened at $12.70.
- Volume was 20.15K shares, 51.1x its 50-day average of 394 — unusually heavy trading.
- Price is +4.1% vs its 50-day average ($12.14) and +4.2% vs its 200-day average ($12.12).
- 52-week range $10.70–$16.27; today's close sits at 35% of that range, 22.4% below the 52-week high.
Oct 7, 2026 — BKHAU ends flat (+0.0%) to $12.25, 4 down days in a row
- Closed at $12.25, +0.00% vs the prior close of $12.25. Day range $12.25–$12.25, opened at $12.25.
- Price is +1.0% vs its 50-day average ($12.12) and +1.1% vs its 200-day average ($12.11).
- 52-week range $10.70–$16.10; today's close sits at 29% of that range, 23.9% below the 52-week high.
- That makes 4 straight losses.
Oct 6, 2026 — BKHAU slides 4.2% to $12.25, 3 down days in a row
- Closed at $12.25, -4.22% vs the prior close of $12.79. Day range $12.25–$12.25, opened at $12.25.
- Volume was 276 shares, 0.6x its 50-day average of 464 — lighter than usual.
- Price is +1.0% vs its 50-day average ($12.13) and +1.1% vs its 200-day average ($12.11).
- 52-week range $10.70–$16.10; today's close sits at 29% of that range, 23.9% below the 52-week high.
- That makes 3 straight losses.
- SEC filings that day: 10-Q.
Oct 5, 2026 — BKHAU ends flat (+0.0%) to $12.79
- Closed at $12.79, +0.00% vs the prior close of $12.79. Day range $12.79–$12.79, opened at $12.79.
- Price is +5.5% vs its 50-day average ($12.12) and +5.6% vs its 200-day average ($12.11).
- 52-week range $10.70–$16.10; today's close sits at 39% of that range, 20.6% below the 52-week high.
Oct 2, 2026 — BKHAU ends flat (+0.0%) to $12.79
- Closed at $12.79, +0.00% vs the prior close of $12.79. Day range $12.79–$12.79, opened at $12.79.
- Price is +5.7% vs its 50-day average ($12.10) and +5.6% vs its 200-day average ($12.11).
- 52-week range $10.70–$16.10; today's close sits at 39% of that range, 20.6% below the 52-week high.
BKHAU latest news & SEC filings
Every SEC filing by or about BKHAU in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 13, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.07 — Reported shareholder vote results.
Oct 7, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Oct 6, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Aug 31, 2026:
- Net income: $1.07M (prior year $154.40K) (+596.1% vs Aug 31, 2025)
Sep 24, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 3.02 — Sold unregistered shares.
Sep 22, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Sep 22, 2026 · Form 424B4 — Final prospectus with offering price
Final prospectus with offering price
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Sep 17, 2026 · Form EFFECT — EFFECT filing
EFFECT filing
Aug 26, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 2.03 — Took on a new material debt or financial obligation.
- Item 3.02 — Sold unregistered shares.
Aug 25, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Jul 22, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Jul 15, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended May 31, 2026:
- Net income: $88.93K (prior year $520.54K) (-82.9% vs May 31, 2025)
Things to know before you trade BKHAU
- How much it moves: over the last 20 sessions the average daily move was 2.27% (largest 12.7%).
- Liquidity: about 3.60K shares (≈$34.84K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $9.69 vs a range of $9.69–$16.27 (0% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Oct 13, 2026; 10-Q Oct 6, 2026; 8-K Sep 24, 2026.
- Share count: 4.15M shares outstanding (Oct 6, 2026), +0.0% vs a year earlier.
- Listing: Nasdaq · industry: Biological Products, (No Diagnostic Substances).
BKHAU market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 9.69 | 9.69 | 9.69 | 9.69 | 151 |
| Oct 14, 2026 | 11.00 | 11.90 | 10.80 | 11.00 | 2.68K |
| Oct 13, 2026 | 13.80 | 14.80 | 11.26 | 12.60 | 10.86K |
| Oct 12, 2026 | 12.64 | 15.90 | 12.64 | 13.01 | 27.15K |
| Oct 9, 2026 | 13.50 | 14.80 | 12.32 | 12.67 | 8.64K |
| Oct 8, 2026 | 12.70 | 16.27 | 12.10 | 12.63 | 20.15K |
| Oct 7, 2026 | 12.25 | 12.25 | 12.25 | 12.25 | 0 |
| Oct 6, 2026 | 12.25 | 12.25 | 12.25 | 12.25 | 276 |
| Oct 5, 2026 | 12.79 | 12.79 | 12.79 | 12.79 | 0 |
| Oct 2, 2026 | 12.79 | 12.79 | 12.79 | 12.79 | 0 |
| Oct 1, 2026 | 12.79 | 12.79 | 12.79 | 12.79 | 200 |
| Sep 30, 2026 | 12.50 | 12.50 | 12.50 | 12.50 | 0 |
| Sep 29, 2026 | 12.50 | 12.50 | 12.50 | 12.50 | 0 |
| Sep 28, 2026 | 12.50 | 12.50 | 12.50 | 12.50 | 316 |
| Sep 25, 2026 | 12.29 | 12.29 | 12.29 | 12.29 | 366 |
| Sep 24, 2026 | 12.25 | 12.25 | 12.25 | 12.25 | 0 |
| Sep 23, 2026 | 12.25 | 12.25 | 12.25 | 12.25 | 0 |
| Sep 22, 2026 | 12.25 | 12.25 | 12.24 | 12.25 | 1.11K |
| Sep 21, 2026 | 11.90 | 11.90 | 11.90 | 11.90 | 0 |
| Sep 18, 2026 | 11.90 | 11.90 | 11.90 | 11.90 | 0 |
About Black Hawk Acquisition
Black Hawk Acquisition (BKHAU) is listed on the Nasdaq and classified by the SEC under “Biological Products, (No Diagnostic Substances)”. Its business address is in DANVILLE, CA. Fiscal year ends November 30. SEC CIK 2000775.
BKHAU board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
BKHAU financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Nov 30, 2025 | — | $1.33M | — | $-650.32K |
| Nov 30, 2024 | — | $1.92M | — | $-553.66K |
Latest balance sheet: total assets $26.03M, total liabilities $4.75M, cash $0 (as of Aug 31, 2026).
BKHAU earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Biological Products, (No Diagnostic Substances)
Moderna (MRNA)Amgen (AMGN)Gilead Sciences (GILD)Twist Bioscience (TWST)Argenx Se (ARGX)Biogen (BIIB)Halozyme Therapeutics (HALO)Revolution Medicines (RVMD)Recursion Pharmaceuticals (RXRX)ImmunityBio (IBRX)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on BKHAU
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.